Concepedia

Jurriaan Brouwer‐Visser

JB

19

Publications

834

Citations

16

H-Index

2010

Active since

Affiliations

Regeneron (United States)(Current)

Albert Einstein College of Medicine

Montefiore Medical Center

Institut Gustave Roussy

National University Hospital

Jurriaan Brouwer‐Visser is an author at Regeneron (United States) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2010–2025

19

Publications

19

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial

Alan Mackay, Anna Burford, Valeria Molinari et al. · Cancer Cell · 2018 · 207 citations · Full text

Insulin-like Growth Factor 2 Expression Modulates Taxol Resistance and Is a Candidate Biomarker for Reduced Disease-Free Survival in Ovarian Cancer

Gloria S. Huang, Jurriaan Brouwer‐Visser, Marissa J. Ramirez et al. · Clinical Cancer Research · 2010 · 94 citations · Full text

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

Tae Min Kim, Michał Taszner, Silvana Novelli et al. · Annals of Oncology · 2024 · 60 citations · Full text

CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models

Joyce Wei, Welby Montalvo-Ortiz, Lola Yu et al. · Science Translational Medicine · 2022 · 49 citations

Regulatory T-cell Genes Drive Altered Immune Microenvironment in Adult Solid Cancers and Allow for Immune Contextual Patient Subtyping

Jurriaan Brouwer‐Visser, Wei‐Yi Cheng, Anna Bauer‐Mehren et al. · Cancer Epidemiology Biomarkers & Prevention · 2017 · 48 citations · Full text

Rows per page

1–5 of 19